Skip to content

To study the application of multimodal nerve ultrasound technology in the evaluation of the efficacy of traditional Chinese medicine in the treatment of diabetic peripheral neuropathy caused by cold-damp obstruction

To study the application of multimodal nerve ultrasound technology in the evaluation of the efficacy of traditional Chinese medicine in the treatment of diabetic peripheral neuropathy caused by cold-damp obstruction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000936
Enrollment
Unknown
Registered
2025-05-09
Start date
2025-02-15
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic peripheral neuropathy

Interventions

treatment group:Take supplemented Jiming powder granules
control group:ake a placebo

Sponsors

Xiyuan Hospital China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) meet the diagnostic criteria of DPN; (2) cold-damp obstruction syndrome according to syndrome differentiation; (3) age between 30 and 75 years old male or female; (4) Patients were able to receive basic treatment. After treatment fasting blood glucose was controlled to 4.4-7.8mmol/l and 2h postprandial blood glucose was controlled to < 13.9mmol/l; (5) Patients were willing to participate in the clinical trial accept follow-up and sign informed consent; (6) All patients volunteered to participate in the study and signed informed consent.

Exclusion criteria

Exclusion criteria: (1) Critically ill patients who did not meet the inclusion criteria; (2) pain caused by other diseases; (3) combined with serious complications such as foot infection stroke sequelae Chronic renal failure pulmonary infection etc. (4) syphilis AIDS hepatitis B and other infectious diseases and coagulation function Disabled persons; (5) combined with cognitive dysfunction and other mental and psychological diseases poor compliance Of; (6) combined with cervical and lumbar diseases; (7) pregnant and lactating women. (8) study patients with drug allergy allergic constitution and pregnancy preparation (9) other patients who were not suitable to participate in relevant clinical trials after evaluation by investigators " (10) Exclusion criteria such as severe abnormal liver or kidney function malignant tumor recent use of similar drugs or participation in similar projects

Design outcomes

Primary

MeasureTime frame
Multimodal ultrasound;Michigan Neuropathy Screening Scale;

Secondary

MeasureTime frame
glycosylated hemoglobin;fasting blood-glucose);

Countries

China

Contacts

Public ContactZhao Mengting Huang Ke

China College of Traditional Chinese Medicine Xiyuan Hospital

88255372@qq.com13810100502

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026